Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Weinberg

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American Medical Directors Association|June 17, 2003
Quality improvement case study: issues involving a nursing facility's obligation to follow its own policiesAndrew D Weinberg
Advances in Experimental Medicine and Biology|August 28, 2010
The role of OX40 (CD134) in T-cell memory generationAndrew D Weinberg
Trends in Immunology|April 4, 2002
OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccinesAndrew D Weinberg
Journal of the American Medical Directors Association|June 17, 2003
Issues involving sexual abuse of nursing facility residentsAndrew D Weinberg
Current Drug Targets. Inflammation and Allergy|April 28, 2005
Modulation of TNF receptor family members to inhibit autoimmune diseaseAndrew D Weinberg, Ryan Montler
Director (Cincinnati, Ohio)|September 19, 2003
Antipsychotic medications and diabetes mellitusAndrew D Weinberg, James D Weinberg
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
OX40-enhanced tumor rejection and effector T cell differentiation decreases with ageCarl E Ruby, Andrew D Weinberg
Advances in Experimental Medicine and Biology|September 18, 2009
OX40 (CD134) and OX40LMichael J Gough, Andrew D Weinberg
International Reviews of Immunology|September 10, 2003
Boosting T cell costimulation in cancer: the possibilities seem endlessDean E Evans, Andrew D Weinberg
Journal of the American Medical Directors Association|June 17, 2003
Quality improvement case study: issues involving elopement of residentsAndrew D Weinberg, Alicia D Weinberg
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Medical Directors Association|June 17, 2003
Quality improvement case study: issues involving a nursing facility's obligation to follow its own policiesAndrew D Weinberg
Advances in Experimental Medicine and Biology|August 28, 2010
The role of OX40 (CD134) in T-cell memory generationAndrew D Weinberg
Trends in Immunology|April 4, 2002
OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccinesAndrew D Weinberg
Journal of the American Medical Directors Association|June 17, 2003
Issues involving sexual abuse of nursing facility residentsAndrew D Weinberg
Current Drug Targets. Inflammation and Allergy|April 28, 2005
Modulation of TNF receptor family members to inhibit autoimmune diseaseAndrew D Weinberg, Ryan Montler
Director (Cincinnati, Ohio)|September 19, 2003
Antipsychotic medications and diabetes mellitusAndrew D Weinberg, James D Weinberg
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
OX40-enhanced tumor rejection and effector T cell differentiation decreases with ageCarl E Ruby, Andrew D Weinberg
Advances in Experimental Medicine and Biology|September 18, 2009
OX40 (CD134) and OX40LMichael J Gough, Andrew D Weinberg
International Reviews of Immunology|September 10, 2003
Boosting T cell costimulation in cancer: the possibilities seem endlessDean E Evans, Andrew D Weinberg
Journal of the American Medical Directors Association|June 17, 2003
Quality improvement case study: issues involving elopement of residentsAndrew D Weinberg, Alicia D Weinberg
Pageof 8